Therapeutic antibodies

Current Molecular Medicine

Volumn 4, Issue 5, 2004, Pages 539-547

  Groner, Bernd ^a   Hartmann, Cord ^a   Wels, Winfried ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALEMTUZUMAB; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; APTAMER; BEVACIZUMAB; CANCER ANTIBODY; CELL SURFACE PROTEIN; CETUXIMAB; DACLIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; GEMTUZUMAB OZOGAMICIN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; IBRITUMOMAB TIUXETAN; IMMUNOTOXIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A4 6 1; MONOCLONAL ANTIBODY MV833; PERTUXUMAB; PERTUZUMAB; POLYPEPTIDE; RITUXIMAB; SIGNAL PEPTIDE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; BREAST CANCER; CANCER; CANCER THERAPY; CARDIOVASCULAR DISEASE; CELL COMPOSITION; CELL CYCLE; CELL SURFACE; CELL SURVIVAL; CELL TRANSFORMATION; CHEMICAL STRUCTURE; CLINICAL TRIAL; CYTOTOXICITY; DIMERIZATION; DRUG ERUPTION; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG RESEARCH; EFFECTOR CELL; GRAFT REJECTION; HEART FAILURE; HUMAN; HYPERSENSITIVITY REACTION; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; LIGAND BINDING; MITOSIS INHIBITION; MOLECULAR SIZE; MOLECULAR WEIGHT; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TARGETING; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TUMOR CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; GENES, ERBB-2; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOTOXINS; MICE; NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE;

EID: 3242706813     PISSN: 15665240     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566524043360483     Document Type: Review

References (25)

1. Koehler, G. and Millstein, C. (1975) Nature, 256, 495-497.
2. Carter, P. (2001) Nature Reviews Cancer, 1, 118-129.
3. Scott, A.M., Wiseman, G., Welt, S., Adjei, A., Lee, F.T., Hopkins, W., Divgi, C.R., Hanson, L.H., Mitchell, P., Gansen, D.N., Larson, S.M., Ingle, J.N., Hoffman, E.W., Tanswell, P., Ritter, G., Cohen, L.S., Bette, P., Arvay, L., Amelsberg, A., Vlock, D., Rettig, W.J., Old, L.J. (2003) Clin. Cancer Res., 9, 1639-1647.
4. Allen Theresa, M. (2002) Nature Reviews Cancer, 2, 750-763
5. Maynard, J. and Georgiou, G. (2000) Annu. Rev. Biomed. Eng., 2, 339-376.
6. Weiner, L. M. and Carter, P. (2003) Nature, 21, 510-511.
7. Horton, J. (2000) Cancer Control, 9, 499-507
8. Mendelsohn, J. and Baselga, J. (2000) Oncogene, 19, 6550-6565.
9. Olayioye, M. A., Neve, R. M., Lane, H. A., and Hynes, N. (2000) EMBO J., 19, 3159-3167.
10. Brekken, R. A., Overholser, J. P., Stastny, V. A., Waltenberger, J., Minna, J. D., and Thorpe, P. E. (2000) Cancer Research, 60, 5117-5124
11. Rosen, L. S. (2002) Cancer Control, 9, 36-44
12. Jorissen, R. N., Walker, F., Pouliot, N., Garrett, T. P. J., Ward, C. W., and Burgess, A. W. (2003) Experimental Cell Research, 284, 31-53
13. Holbro, T., Gianluca, C. and Hynes, N. (2003) Experimental Cell Research, 284, 99-110
14. Yarden, Y. (2001) European Journal of Cancer, 37, S3-S8
15. Arteaga, C. L. (2003) Experimental Cell Research, 284, 122-130
16. Mendelsohn, J. (2003) Cancer Immunol. Immunother., 52, 342-346
17. Sliwkowski, M. X., Lofgren, J. A., Lewis, G. D., Hotaling, T. E., Fendly, B. M., and Fox, J. A. (1999) Semin. Oncol., 26 (4 Suppl 12), 60-70.
18. Vogel, C. L.; Cobleigh, M. A., Tripathy, D. Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M. Shak, S., Stewart, S. J., and Press, M. (2002) Journal of Clinical Oncology, 20, 719-726
19. Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., Baselga, J., and Norton, L. (2001) The New England Journal of Medicine, 344, 783-792
20. Holbro, T., Beerli, R. R., Maurer, F., Koziczak, M., Barbas, C. F., and Hynes, N. (2003) PNAS, 100, 8933-8938
21. Agus, D. B., Akita, R. W., Fox, W. D., Lewis, G. D., Higgins, B., Pisacane, P. I., Lofgren, J. A., Tindell, C., Evans, D. P., Maiese, K., Scher, H. I., and Sliwkowski, M. X. (2002) Cancer Cell, 2, 127-137.
22. Pastan, I. (2003) Cancer Immunol Immunother, 52, 338-341.
23. Azemar, M., Schmidt, M., Arit, F., Kennel, P., Brandt, B., Papadimitriou, A., Groner, B., and Wels, W. (2000) Int. J. Cancer, 86, 269-275.
24. Kreitman, R. J., Wilson, W. H., White, J. D., Stetler-Stevenssohn, M., Jaffe, E. S., Giardina, S., Waldmann, T. A., and Pastan, I. (2002) J. Clin. Oncol., 18, 1622-1636.
25. Azemar, M., Djahansouzi, S., Jäger, E., Solbach, C., Schmidt, M., Maurer, A. B., Mross, K., Unger, C., von Minckwitz, G., Dall, P., Groner, B., Wels, W. (2003) Proceedings AACR 94th Annual Meeting pp. LB-164: Washington, D.C.